Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer

被引:0
作者
Juan Luis Gomez Marti
Colin H. Beckwitt
Amanda M. Clark
Alan Wells
机构
[1] University of Pittsburgh,Department of Pathology
[2] R & D Service,UPMC Hillman Cancer Center
[3] Pittsburgh VA Health System,Department of Computational & Systems Biology
[4] University of Pittsburgh,Department of Bioengineering
[5] University of Pittsburgh,undefined
[6] University of Pittsburgh,undefined
来源
British Journal of Cancer | 2021年 / 125卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1285 / 1298
页数:13
相关论文
共 273 条
[1]  
Dent R(2009)Pattern of metastatic spread in triple-negative breast cancer Breast Cancer Res Treat. 115 423-8
[2]  
Hanna WM(2019)NCCN guidelines updates: breast cancer J Natl Compr Canc Netw. 17 552-5
[3]  
Trudeau M(2003)Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases Breast Cancer Res Treat 82 199-206
[4]  
Rawlinson E(2013)Prospective analysis of association between statin use and breast cancer risk in the women’s health initiative Cancer Epidemiol Biomark Prev. 22 1868-76
[5]  
Sun P(2015)Statins and breast cancer stage and mortality in the Women’s Health Initiative Cancer Causes Control. 26 529-39
[6]  
Narod SA(2016)The association between treatment for metabolic disorders and breast cancer characteristics Int J Endocrinol 2016 4658469-305
[7]  
Telli ML(2018)Statin use and risk of contralateral breast cancer: a nationwide cohort study Br J Cancer. 119 1297-65
[8]  
Gradishar WJ(2017)Effect of statins on breast cancer recurrence and mortality: a review Breast Cancer (Dove Med Press). 9 559-25
[9]  
Ward JH(2005)Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update Fundam Clin Pharmacol. 19 117-87
[10]  
Naumov GN(2001)Statins: mechanism of action and effects J Cell Mol Med 5 378-57